- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

FDA to review Samsung Bioepis and Biogen’s biosimilar SB11

Biosimilars are products that are similar in efficacy and safety to the originator’s reference product. Credit: Myriams-Fotos from Pixabay.